A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)
NCT00312351
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
262
Enrollment
INDUSTRY
Sponsor class
Conditions
Macular Degeneration
Interventions
DRUG:
Pegaptanib sodium
Sponsor
Eyetech Pharmaceuticals
Collaborators
[object Object]